Lauren Silvernail
Direktor/Vorstandsmitglied bei NICOX SA
Vermögen: 234 013 $ am 30.04.2024
Aktive Positionen von Lauren Silvernail
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NICOX SA | Direktor/Vorstandsmitglied | 18.05.2017 | - |
Independent Dir/Board Member | 18.05.2017 | - | |
HARROW, INC. | Direktor/Vorstandsmitglied | 29.01.2024 | - |
Independent Dir/Board Member | 26.01.2024 | - | |
Licensing Executives Society | Corporate Officer/Principal | - | - |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Direktor/Vorstandsmitglied | 01.01.2017 | - |
Karriereverlauf von Lauren Silvernail
Ehemalige bekannte Positionen von Lauren Silvernail
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HARPOON THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 15.09.2022 | 11.03.2024 |
Independent Dir/Board Member | 15.09.2022 | 11.03.2024 | |
EVOLUS, INC. | Finanzdirektor/CFO | 29.05.2018 | 31.05.2022 |
Investor Relations Kontakt | - | 30.06.2021 | |
REVANCE THERAPEUTICS, INC. | Finanzdirektor/CFO | 03.04.2013 | 29.05.2018 |
Unternehmenssekretär | 25.03.2013 | 01.05.2018 | |
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Comptroller/Controller/Auditor | 01.03.2003 | 01.01.2012 |
Finanzdirektor/CFO | 01.03.2003 | 01.01.2012 | |
Public Communications Contact | 01.03.2003 | 01.01.2012 | |
ALLERGAN, INC. | Corporate Officer/Principal | 01.01.1995 | 01.03.2003 |
░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Lauren Silvernail
University of California, Berkeley | Undergraduate Degree |
UCLA Anderson School of Management | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 14 |
Frankreich | 2 |
Operativ
Corporate Officer/Principal | 5 |
Director/Board Member | 4 |
Director of Finance/CFO | 3 |
Sektoral
Health Technology | 11 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 6 |
---|---|
REVANCE THERAPEUTICS, INC. | Health Technology |
BIO-RAD LABORATORIES, INC. | Health Technology |
NICOX SA | Health Technology |
EVOLUS, INC. | Health Technology |
HARPOON THERAPEUTICS, INC. | Health Technology |
HARROW, INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
ISTA Pharmaceuticals, Inc.
ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Health Technology |
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
Glenwood Ventures
Glenwood Ventures Investment ManagersFinance Glenwood Ventures is a commercial real estate investment firm that specializes in acquiring and developing various types of real estate assets, including industrial, office, life science, residential, and mixed-use properties. Glenwood Ventures was founded in 1900 and is based in Menlo Park, CA. The private company's team members have extensive experience in maximizing real estate value by identifying opportunities and operating assets for their clients and partners. | Finance |
Varian Medical Systems, Inc.
Varian Medical Systems, Inc. Medical SpecialtiesHealth Technology Varian Medical Systems, Inc. engages in the manufacture of medical devices and software for treating cancer and other medical conditions. It operates through the Oncology Systems and Proton Solutions segments. The Oncology Systems segment designs, manufactures, sells, and services hardware and software products for treating cancer with conventional radiation therapy, and advanced treatments. The Proton Solutions segment delivers proton therapy, a form of external beam radiotherapy using proton beams for the treatment of cancer. The company was founded by William Hansen, Edward Ginzton, Russell Varian, and Sigurd Varian in 1948 and is headquartered in Palo Alto, CA. | Health Technology |
Licensing Executives Society | |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | Health Technology |
- Börse
- Insiders
- Lauren Silvernail
- Erfahrung